Background. Several groups have demonstrated that non-heart beating donation is a viable source of organs for transplantation. However, the theoretically worse graft function and survival of the kidneys obtained from non-heart beating donors (NHBDs) is still a matter of debate that has led to consider them as marginal donors for kidney transplantation. Methods. In this report, we compare the outcome and course of 83 kidney transplants from NHBDs with those corresponding to 3177 adult cadaveric heart beating donor (HBD) transplants performed over the same period in our country. Graft and patient survival were estimated by means of Kaplan-Meier analysis. In addition, groups were compared using Cox proportional regression. Results. The delayed graft function (DGF) rate was higher on NHBD transplants than in HBD kidneys (58.8 vs 28.9%, P<0.0001). However, in 1998, where the highest number of NHBD transplants was performed, graft function estimated by serum creatinine levels at 3 months and 1 year, was significantly better in the NHBD transplant group (1.42±0.45 vs 1.66±0.66 and 1.45±0.59 vs 1.62±0.64, respectively, P ¼ 0.01 and 0.07). Graft survival at 2 years was 97%, 95% at 4 years and 84% at 6 years for NHBDs and 97, 90 and 84%, respectively, for HBDs. Interestingly, DGF was a risk factor for worse graft survival in HBDs but not on NHBDs. Conclusions. We conclude that, in our study, both graft function and graft survival of NHBD kidney transplants are at least similar to those from HBD transplants. Therefore, NHBDs should be considered as a viable source of non-marginal kidneys for transplant.
Introduction
Owing to an ever-increasing number of patients receiving treatment for end-stage renal disease and the adoption of less restrictive criteria for inclusion in the kidney transplant waiting list, there is a growing need for cadaveric kidney donors. Numerous efforts have been made to increase organ donation, and cadaveric kidney donations in Spain have risen, particularly among the older age groups [1] . These measures have led to reduced waiting times as the waiting list gets shorter [1] . At different centres, the shortage of kidneys has prompted the use of non-heart beating donors (NHBDs). The aim of this paper was both to compare the survival of transplant kidneys from NHBDs with those of kidneys procured from heart beating donors (HBDs) and to conduct a study of the survival and renal function of transplant kidneys from NHBDs and HBDs, taking into consideration the inter-relationship with delayed graft function (DGF).
Subjects and methods
In this report, we compare the outcome and course of 83 kidney transplants from NHBDs with those corresponding to 3177 adult cadaveric HBD transplants performed over the same period in our country.
Graft and patient survival were estimated by means of Kaplan-Meier analysis. In addition, groups were compared using Cox proportional hazards regression.
Results Table 1 provides the incidence of HBDs/NHBDs for each year of transplantation (no significant differences were found). Table 2 describes creatinine evaluated at 3 months and 1 year post-transplantation, and creatinine changes from 3 months to 1 year in HBDs and NHBDs. In 1998, the highest number of NHBD transplants was performed; there was a trend for better serum creatinine at 1 year in the NHBD transplant group (P ¼ 0.07). When analysing only patients with DGF (Table 3) , both creatinine at 3 months and 1 year were significantly higher for HBDs. The proteinuria values at 1 year post-transplantation were significantly lower in NHBD transplants (0.23±0.31 vs 0.35±0.88 g/24 h in the HBD transplants, P ¼ 0.05)
The NHBD transplants showed DGF rates of 58.8 vs 28.9% in the HBD transplants (P<0.0001). Multiple regression analysis of risk factors for DGF is provided in Table 4 . As can be seen, the NHBD transplant is an independent risk factor for a DGF of 4.3 (95% CI 2.6-7.0).
Comparison of graft survival between HBDs and NHBDs
Overall Kaplan-Meier estimates of graft survival for HBDs and NHBDs are shown in Figure 1 . Cox regression showed no significant differences. Graft survival at 2 years was 97%, 95% at 4 years and 84% at 6 years for NHBDs and 97, 90 and 84%, respectively, for HBDs.
The presence of DGF in the HBD organ recipients led to lower graft survival (P<0.0001) (Figure 2 ) but not in type I NHBD transplants (P ¼ 0.92). Cox regression showed that the presence of DGF is a risk factor for graft survival (Table 5) but not in NHBD transplants.
Comparison of patient survival between HBDs and NHBDs
Overall Kaplan-Meier estimates of patient survival for HBDs and NHBDs are shown in Figure 3 . No significant differences between both groups were found.
Discussion
NHBDs were the primary source of kidney allografts in the early years of clinical transplantation, an era Chi-square test, P ¼ 0.2606.
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when death was defined as the moment when cardiac activity ceased. Because the period of warm ischaemia was often prolonged before revascularization, many grafts failed to function. The poor outcome of these grafts together with the later establishment of criteria for brain death in the 1960s resulted in the practical abrogation of non-heart beating donation on most transplantation programmes. The everincreasing number of patients undergoing dialysis, together with less restrictive transplant criteria, have led to a shortage of cadaveric kidneys for transplant. At the end of the year 2000, out of a total population approaching 39 million, 3986 patients were waiting for a kidney transplant in our country and the number of kidneys harvested from HBDs has stabilized [2] . Although there is a need to extend the use of brain-dead HBDs, there is still room for additional sources of organs, and this has prompted the use of NHBDs. It has been estimated that NHBDs permit a 7-40% increase in the number of transplants performed [3] [4] [5] [6] [7] [8] [9] [10] .
In accordance with the findings of others [5, 8, [10] [11] [12] [13] [14] , this series of renal transplants from NHBDs demonstrate an excellent long-term graft survival and renal function, although reduced NHBD graft survival rates have been previously reported by others [3, 7, 9] .
Patients receiving NHBD kidneys underwent longer periods of oligoanuria and required longer periods of haemodialysis in accordance with data published by other authors [3] [4] [5] [6] [7] [8] [9] [10] [11] 13, 14] . Interestingly, delayed function of the NHBD graft was not associated with poorer graft outcome in our series, although due to the reduced number of subjects available, the analysis is not powered enough to ensure it. Moreover, it should be highlighted that renal function in 1998-when the highest number of NHBD transplants was performed-was better at 1 year in the NHBD transplants with respect to HBD transplants. We considered the possibility that factors related to brain death might be detrimental for the outcome of HBD transplants. The kidney has a remarkable capacity to recover from an acute non-specific insult, such as the effects of donor brain death. If the insult is too severe, however, renal function may never return to baseline. Indeed, the damaged organ may develop progressive functional deterioration and irreversible chronic structural changes. Therefore, if DGF is interpreted as a possible mark for severe injury associated with brain death, it is not surprising that when renal function is compared only between patients that suffer DGF, HBD transplants achieve worse renal function than NHBD transplants. These clinical findings may support the accumulating evidence that severe brain lesions mediate detrimental effects on the graft. Severe injury of the brain is associated with a massive release of pro-inflammatory cytokines [15] [16] [17] , and high-level expression of vascular and tubular adhesion molecules and MHC II is seen in kidneys from human cadaver donors as opposed to living-related grafts [18] . Table 3 . Comparison of creatinine between heart/non-heart beating, only for patients with DGF From our results, it may be concluded that the NHBDs represent a viable source of non-marginal kidneys for transplant. Although the use of brain-dead donors with beating hearts could be extended, there is still much need for additional sources. The authors feel that every effort should be made to encourage transplant centres that have not yet considered the use of NHBDs to do so. This may permit a substantial reduction in the ever-growing list of patients waiting for transplant. 
